Mohanad Hadi
Internal Medicine · San Diego, CANPI 1194258087
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,744 of the $4,295 with a category attached, or 87.2%. 14 manufacturers reported payments, led by AbbVie at 26.0% of the total. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 139 payments — averaging $30.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$699
- GSK$608
- Amgen$411
- Novartis$315
- Mallinckrodt Hospital Products Inc.$308
- plus $839 from 8 others
What the payments were for
- Food & beverage$3,74487%
- Education$55113%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 69 | $1,115 |
| Johnson & Johnson | 11 | $699 |
| GSK | 17 | $608 |
| Amgen | 9 | $411 |
| Novartis | 5 | $315 |
| Mallinckrodt Hospital Products Inc. | 6 | $308 |
| UCB, Inc. | 8 | $265 |
| AstraZeneca(2 entities) | 8 | $254 |
| Sanofi | 1 | $123 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Lilly USA, LLC | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Boehringer Ingelheim | 1 | $25 |
| Pfizer | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,295 in reported general payments places this provider in the 90th percentile of 13,581 internal medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 21 | $170,540 |
| Enbrel SureclickEtanercept | 19 | $132,965 |
| RasuvoMethotrexate/Pf | 15 | $8,229 |
| Hydroxychloroquine Sulfate | 64 | $2,236 |
| Colchicine | 15 | $1,361 |
| Leflunomide | 15 | $1,243 |
| MethotrexateMethotrexate Sodium | 50 | $1,135 |
| Mycophenolate Mofetil | 11 | $931 |
| Diclofenac Sodium | 32 | $794 |
| Prednisone | 57 | $330 |
| Celecoxib | 20 | $296 |
| Leucovorin Calcium | 15 | $281 |
| Duloxetine Hcl | 11 | $239 |
| Alendronate Sodium | 27 | $124 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in San Diego
- Hatim HusainSan Diego$2M
- Steven EdelmanSan Diego$863K
- Christian RamersSan Diego$675K
- Adam ZweigSan Diego$421K
- James BreitmeyerSan Diego$227K
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Teck LingPalo Alto$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.